Nancy B. Gardiner’s Bristol-Myers Squibb BMY Stock Holding History

Nancy B. Gardiner’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-3,400	Closed	-$217K	–	47
2017 Q3	$217K	Buy	+3,400	New	+$199K	0.4%	53
2016 Q3	–	Sell	-3,590	Closed	-$264K	–	53
2016 Q2	$264K	Buy	3,590 +190	+6%	+$13.4K	0.85%	47
2016 Q1	$217K	Hold	3,400	–	–	0.93%	42
2015 Q4	$234K	Buy	+3,400	New	+$225K	1.14%	40

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Nancy B. Gardiner's BMY Position: Q4 2017 in Review

Nancy B. Gardiner sold out of Bristol-Myers Squibb (BMY) in Q4 2017, closing a stake of 3,400 shares — an estimated $217K sold.

Nancy B. Gardiner first reported a position in BMY in Q4 2015 and held it in 4 quarters. The position peaked at $264K in Q2 2016. 1,736 funds tracked by Wall St. Rank hold BMY as of Q4 2017.

Nancy B. Gardiner reported no remaining Bristol-Myers Squibb position as of Q4 2017 after selling out during the quarter.
Nancy B. Gardiner sold 3,400 Bristol-Myers Squibb shares in Q4 2017, an estimated $217K.
Nancy B. Gardiner first reported a position in Bristol-Myers Squibb in Q4 2015 and held it in 4 quarters.
Nancy B. Gardiner's Bristol-Myers Squibb position peaked at $264K in Q2 2016.
1,736 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2017.

Based on Nancy B. Gardiner's 13F filing for Q4 2017, filed 2 Feb 2018.